ClinVar Genomic variation as it relates to human health
NM_000090.4(COL3A1):c.3818A>G (p.Lys1273Arg)
The aggregate germline classification for this variant, typically for a monogenic or Mendelian disorder as in the ACMG/AMP guidelines, or for response to a drug. This value is calculated by NCBI based on data from submitters. Read our rules for calculating the aggregate classification.
Stars represent the aggregate review status, or the level of review supporting the aggregate germline classification for this VCV record. This value is calculated by NCBI based on data from submitters. Read our rules for calculating the review status. The number of submissions which contribute to this review status is shown in parentheses.
Uncertain significance(4); Benign(1); Likely benign(5)
No data submitted for somatic clinical impact
No data submitted for oncogenicity
Variant Details
- Identifiers
-
NM_000090.4(COL3A1):c.3818A>G (p.Lys1273Arg)
Variation ID: 199744 Accession: VCV000199744.56
- Type and length
-
single nucleotide variant, 1 bp
- Location
-
Cytogenetic: 2q32.2 2: 189009216 (GRCh38) [ NCBI UCSC ] 2: 189873942 (GRCh37) [ NCBI UCSC ]
- Timeline in ClinVar
-
First in ClinVar Help The date this variant first appeared in ClinVar with each type of classification.
Last submission Help The date of the most recent submission for each type of classification for this variant.
Last evaluated Help The most recent date that a submitter evaluated this variant for each type of classification.
Germline Oct 2, 2016 Sep 16, 2024 Jan 30, 2024 - HGVS
-
Nucleotide Protein Molecular
consequenceNM_000090.4:c.3818A>G MANE Select Help Transcripts from the Matched Annotation from the NCBI and EMBL-EBI (MANE) collaboration.
NP_000081.2:p.Lys1273Arg missense NC_000002.12:g.189009216A>G NC_000002.11:g.189873942A>G NG_007404.1:g.39844A>G LRG_3:g.39844A>G LRG_3t1:c.3818A>G LRG_3p1:p.Lys1273Arg - Protein change
- K1273R
- Other names
-
p.K1273R:AAG>AGG
- Canonical SPDI
- NC_000002.12:189009215:A:G
-
Functional
consequence HelpThe effect of the variant on RNA or protein function, based on experimental evidence from submitters.
- -
-
Global minor allele
frequency (GMAF) HelpThe global minor allele frequency calculated by the 1000 Genomes Project. The minor allele at this location is indicated in parentheses and may be different from the allele represented by this VCV record.
-
0.00020 (G)
-
Allele frequency
Help
The frequency of the allele represented by this VCV record.
-
Exome Aggregation Consortium (ExAC) 0.00008
The Genome Aggregation Database (gnomAD) 0.00011
The Genome Aggregation Database (gnomAD), exomes 0.00013
Trans-Omics for Precision Medicine (TOPMed) 0.00015
1000 Genomes Project 30x 0.00016
1000 Genomes Project 0.00020
NHLBI Exome Sequencing Project (ESP) Exome Variant Server 0.00031
- Links
Genes
Gene | OMIM | ClinGen Gene Dosage Sensitivity Curation |
Variation Viewer
Help
Links to Variation Viewer, a genome browser to view variation data from NCBI databases. |
Related variants | ||
---|---|---|---|---|---|---|
HI score
Help
The haploinsufficiency score for the gene, curated by ClinGen’s Dosage Sensitivity Curation task team. |
TS score
Help
The triplosensitivity score for the gene, curated by ClinGen’s Dosage Sensitivity Curation task team. |
Within gene
Help
The number of variants in ClinVar that are contained within this gene, with a link to view the list of variants. |
All
Help
The number of variants in ClinVar for this gene, including smaller variants within the gene and larger CNVs that overlap or fully contain the gene. |
|||
COL3A1 | Sufficient evidence for dosage pathogenicity | No evidence available |
GRCh38 GRCh38 GRCh37 |
3056 | 3185 |
Conditions - Germline
Condition
Help
The condition for this variant-condition (RCV) record in ClinVar. |
Classification
Help
The aggregate germline classification for this variant-condition (RCV) record in ClinVar. The number of submissions that contribute to this aggregate classification is shown in parentheses. (# of submissions) |
Review status
Help
The aggregate review status for this variant-condition (RCV) record in ClinVar. This value is calculated by NCBI based on data from submitters. Read our rules for calculating the review status. |
Last evaluated
Help
The most recent date that a submitter evaluated this variant for the condition. |
Variation/condition record
Help
The RCV accession number, with most recent version number, for the variant-condition record, with a link to the RCV web page. |
---|---|---|---|---|
Uncertain significance (1) |
criteria provided, single submitter
|
May 23, 2017 | RCV000515270.10 | |
Conflicting interpretations of pathogenicity (4) |
criteria provided, conflicting classifications
|
Dec 23, 2023 | RCV000725829.24 | |
Conflicting interpretations of pathogenicity (3) |
criteria provided, conflicting classifications
|
Oct 1, 2021 | RCV000771822.16 | |
Benign/Likely benign (2) |
criteria provided, multiple submitters, no conflicts
|
Jan 30, 2024 | RCV001087510.19 |
Submissions - Germline
Classification
Help
The submitted germline classification for each SCV record. (Last evaluated) |
Review status
Help
Stars represent the review status, or the level of review supporting the submitted (SCV) record. This value is calculated by NCBI based on data from the submitter. Read our rules for calculating the review status. This column also includes a link to the submitter’s assertion criteria if provided, and the collection method. (Assertion criteria) |
Condition
Help
The condition for the classification, provided by the submitter for this submitted (SCV) record. This column also includes the affected status and allele origin of individuals observed with this variant. |
Submitter
Help
The submitting organization for this submitted (SCV) record. This column also includes the SCV accession and version number, the date this SCV first appeared in ClinVar, and the date that this SCV was last updated in ClinVar. |
More information
Help
This column includes more information supporting the classification, including citations, the comment on classification, and detailed evidence provided as observations of the variant by the submitter. |
|
---|---|---|---|---|---|
Uncertain significance
(May 23, 2017)
|
criteria provided, single submitter
Method: clinical testing
|
Ehlers-Danlos syndrome, type 3
Ehlers-Danlos syndrome, type 4
Affected status: unknown
Allele origin:
unknown
|
Fulgent Genetics, Fulgent Genetics
Accession: SCV000611385.1
First in ClinVar: Nov 11, 2017 Last updated: Nov 11, 2017 |
|
|
Likely benign
(Oct 08, 2019)
|
criteria provided, single submitter
Method: clinical testing
|
Familial thoracic aortic aneurysm and aortic dissection
Affected status: unknown
Allele origin:
germline
|
Color Diagnostics, LLC DBA Color Health
Accession: SCV000904527.2
First in ClinVar: May 20, 2019 Last updated: Jun 22, 2020 |
|
|
Likely benign
(Jul 02, 2021)
|
criteria provided, single submitter
Method: clinical testing
|
Not provided
Affected status: unknown
Allele origin:
germline
|
Johns Hopkins Genomics, Johns Hopkins University
Accession: SCV001762374.1
First in ClinVar: Jul 31, 2021 Last updated: Jul 31, 2021 |
|
|
Uncertain significance
(Oct 01, 2021)
|
criteria provided, single submitter
Method: clinical testing
|
Familial thoracic aortic aneurysm and aortic dissection
Affected status: unknown
Allele origin:
germline
|
CHEO Genetics Diagnostic Laboratory, Children's Hospital of Eastern Ontario
Accession: SCV003838691.1
First in ClinVar: Mar 11, 2023 Last updated: Mar 11, 2023 |
|
|
Likely benign
(Jan 30, 2024)
|
criteria provided, single submitter
Method: clinical testing
|
Ehlers-Danlos syndrome, type 4
Affected status: unknown
Allele origin:
germline
|
Labcorp Genetics (formerly Invitae), Labcorp
Accession: SCV000262437.9
First in ClinVar: Jan 31, 2016 Last updated: Feb 14, 2024 |
|
|
Likely benign
(Jul 17, 2020)
|
criteria provided, single submitter
Method: clinical testing
|
Familial thoracic aortic aneurysm and aortic dissection
Affected status: unknown
Allele origin:
germline
|
Ambry Genetics
Accession: SCV000319224.7
First in ClinVar: Oct 02, 2016 Last updated: May 01, 2024 |
Comment:
This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of … (more)
This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. (less)
|
|
Uncertain significance
(Mar 03, 2016)
|
criteria provided, single submitter
Method: clinical testing
|
not provided
Affected status: unknown
Allele origin:
germline
|
Eurofins Ntd Llc (ga)
Accession: SCV000339677.4
First in ClinVar: Dec 06, 2016 Last updated: Dec 15, 2018 |
Number of individuals with the variant: 1
Sex: mixed
|
|
Benign
(Apr 28, 2017)
|
criteria provided, single submitter
Method: clinical testing
|
Ehlers-Danlos syndrome, type 4
Affected status: unknown
Allele origin:
germline
|
Illumina Laboratory Services, Illumina
Accession: SCV001299204.1
First in ClinVar: May 31, 2020 Last updated: May 31, 2020 |
Comment:
This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, … (more)
This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. The evidence from the literature, in combination with allele frequency data from public databases where available, was sufficient to rule this variant out of causing disease. Therefore, this variant is classified as benign. (less)
|
|
Likely benign
(Nov 09, 2021)
|
criteria provided, single submitter
Method: clinical testing
|
not provided
Affected status: unknown
Allele origin:
germline
|
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Accession: SCV002048320.1
First in ClinVar: Jan 08, 2022 Last updated: Jan 08, 2022 |
|
|
Uncertain significance
(Dec 23, 2023)
|
criteria provided, single submitter
Method: clinical testing
|
Not Provided
Affected status: yes
Allele origin:
germline
|
GeneDx
Accession: SCV000233388.15
First in ClinVar: Jul 05, 2015 Last updated: Sep 16, 2024 |
Comment:
Identified in individuals with arterial dissection and/or aneurysm in the published literature and classified as a variant of uncertain significance (PMID: 26854089, 25758994, 20825986); Identified … (more)
Identified in individuals with arterial dissection and/or aneurysm in the published literature and classified as a variant of uncertain significance (PMID: 26854089, 25758994, 20825986); Identified in a proband with spontaneous iliac artery dissection in the published literature, but the variant did not segregate with disease in this family; a second cardiogenetic variant in the COL1A1 gene was identified in the proband that segregated with disease and was classified by the authors as pathogenic (PMID: 31531849); Identified in a patient with Marfan syndrome who also harbored a likely pathogenic variant in the FBN1 gene (PMID: 30087447); Not located in the triple helical region, where the majority of pathogenic missense variants occur (HGMD); In silico analysis supports that this missense variant does not alter protein structure/function; Also known as p.(K1106R); This variant is associated with the following publications: (PMID: 29590070, 25758994, 20825986, 31531849, 26854089, 30087447) (less)
|
Germline Functional Evidence
There is no functional evidence in ClinVar for this variation. If you have generated functional data for this variation, please consider submitting that data to ClinVar. |
Citations for germline classification of this variant
HelpTitle | Author | Journal | Year | Link |
---|---|---|---|---|
Classical Ehlers-Danlos syndrome with a propensity to arterial events: A new report on a French family with a COL1A1 p.(Arg312Cys) variant. | Adham S | Clinical genetics | 2020 | PMID: 31531849 |
Type III collagen (COL3A1): Gene and protein structure, tissue distribution, and associated diseases. | Kuivaniemi H | Gene | 2019 | PMID: 31075413 |
Association of modifiers and other genetic factors explain Marfan syndrome clinical variability. | Aubart M | European journal of human genetics : EJHG | 2018 | PMID: 30087447 |
Phenotype risk scores identify patients with unrecognized Mendelian disease patterns. | Bastarache L | Science (New York, N.Y.) | 2018 | PMID: 29590070 |
Application of Whole Exome Sequencing in the Clinical Diagnosis and Management of Inherited Cardiovascular Diseases in Adults. | Seidelmann SB | Circulation. Cardiovascular genetics | 2017 | PMID: 28087566 |
Clinically relevant variants identified in thoracic aortic aneurysm patients by research exome sequencing. | Schubert JA | American journal of medical genetics. Part A | 2016 | PMID: 26854089 |
The type of variants at the COL3A1 gene associates with the phenotype and severity of vascular Ehlers-Danlos syndrome. | Frank M | European journal of human genetics : EJHG | 2015 | PMID: 25758994 |
Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. | Richards S | Genetics in medicine : official journal of the American College of Medical Genetics | 2015 | PMID: 25741868 |
http://www.egl-eurofins.com/emvclass/emvclass.php?approved_symbol=COL3A1 | - | - | - | - |
Text-mined citations for rs144614075 ...
HelpRecord last updated Nov 25, 2024
This date represents the last time this VCV record was updated. The update may be due to an update to one of the included submitted records (SCVs), or due to an update that ClinVar made to the variant such as adding HGVS expressions or a rs number. So this date may be different from the date of the “most recent submission” reported at the top of this page.